Merck & Co/Wellcome venture links with MEND for developing world rotavirus vaccine
This article was originally published in Scrip
Executive Summary
MSD Wellcome Trust Hilleman Laboratories, an R&D joint venture between Merck & Co and the Wellcome Trust, and the vaccine technology group, Medicine in Need (MEND), plan to develop a rotavirus vaccine that specifically addresses developing world challenges, including inadequate delivery infrastructure and high costs.